Literature DB >> 12084760

Ocular and systemic posaconazole(SCH-56592) treatment of invasive Fusarium solani keratitis and endophthalmitis.

W E Sponsel, J R Graybill, H L Nevarez, D Dang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12084760      PMCID： PMC1771206          DOI： 10.1136/bjo.86.7.829-a

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  10 in total

Review 1.  New targets and delivery systems for antifungal therapy.

Authors:  T J Walsh; M A Viviani; E Arathoon; C Chiou; M Ghannoum; A H Groll; F C Odds
Journal:  Med Mycol       Date:  2000       Impact factor: 4.076

Review 2.  New investigational antifungal agents for treating invasive fungal infections.

Authors:  M A Hossain; M A Ghannoum
Journal:  Expert Opin Investig Drugs       Date:  2000-08       Impact factor: 6.206

3.  Structural characterization of the oxidative degradation products of an antifungal agent SCH 56592 by LC-NMR and LC-MS.

Authors:  W Feng; H Liu; G Chen; R Malchow; F Bennett; E Lin; B Pramanik; T M Chan
Journal:  J Pharm Biomed Anal       Date:  2001-06       Impact factor: 3.935

4.  In vitro and in vivo experimental activities of antifungal agents against Fusarium solani.

Authors:  J Guarro; I Pujol; E Mayayo
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

5.  In vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and Candida.

Authors:  A Cacciapuoti; D Loebenberg; E Corcoran; F Menzel; E L Moss; C Norris; M Michalski; K Raynor; J Halpern; C Mendrick; B Arnold; B Antonacci; R Parmegiani; T Yarosh-Tomaine; G H Miller; R S Hare
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

6.  In vitro antifungal activity of posaconazole against various pathogenic fungi.

Authors:  K Uchida; N Yokota; H Yamaguchi
Journal:  Int J Antimicrob Agents       Date:  2001-08       Impact factor: 5.283

Review 7.  Changing strategies for treatment of systemic mycoses.

Authors:  J R Graybill
Journal:  Braz J Infect Dis       Date:  2000-04       Impact factor: 1.949

8.  Fungal keratitis in a soft contact lens wearer.

Authors:  R Foroozan; R C Eagle; E J Cohen
Journal:  CLAO J       Date:  2000-07

9.  [Ocular parasitoses and mycoses: cases diagnosed in the Central University Hospital of Sfax between 1996 and 1999].

Authors:  F Cheikh-Rouhou; F Makni; A Ayadi; R Ghorbel; Z Ben Zina
Journal:  Bull Soc Pathol Exot       Date:  2001-03

10.  Polymicrobial keratitis after laser in situ keratomileusis.

Authors:  V Gupta; T Dada; R B Vajpayee; N Sharma; V K Dada
Journal:  J Refract Surg       Date:  2001 Mar-Apr       Impact factor: 3.573
  10 in total
  27 in total

1.  Fusarium keratitis and endophthalmitis associated with lens contact wear.

Authors:  Julia Proença-Pina; Isabelle Ssi Yan Kai; Tristan Bourcier; Monique Fabre; Hervé Offret; Marc Labetoulle
Journal:  Int Ophthalmol       Date:  2009-04-10       Impact factor: 2.031

2.  Successful treatment of Paecilomyces lilacinus keratitis with oral posaconazole.

Authors:  Michael A Arnoldner; Ahmad Kheirkhah; Frederick A Jakobiec; Marlene L Durand; Pedram Hamrah
Journal:  Cornea       Date:  2014-07       Impact factor: 2.651

3.  Multidrug-resistant Fusarium keratitis: diagnosis and treatment considerations.

Authors:  Sergio Sara; Kendall Sharpe; Sharon Morris
Journal:  BMJ Case Rep       Date:  2016-08-03

4.  Comparative Evaluation of Etest, EUCAST, and CLSI Methods for Amphotericin B, Voriconazole, and Posaconazole against Clinically Relevant Fusarium Species.

Authors:  Abdullah M S Al-Hatmi; Anne-Cécile Normand; Stephane Ranque; Renaud Piarroux; G Sybren de Hoog; Joseph Meletiadis; Jacques F Meis
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

5.  Outbreak of fungal endophthalmitis due to Fusarium oxysporum following cataract surgery.

Authors:  Vladimír Buchta; Alena Feuermannová; Martin Váša; Lenka Bašková; Radka Kutová; Alena Kubátová; Marcela Vejsová
Journal:  Mycopathologia       Date:  2014-01-01       Impact factor: 2.574

6.  In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial.

Authors:  Prajna Lalitha; Catherine Q Sun; N Venkatesh Prajna; Rajarathinam Karpagam; Manoharan Geetha; Kieran S O'Brien; Vicky Cevallos; Stephen D McLeod; Nisha R Acharya; Thomas M Lietman
Journal:  Am J Ophthalmol       Date:  2013-10-22       Impact factor: 5.258

7.  Current Thoughts in Fungal Keratitis: Diagnosis and Treatment.

Authors:  Zubair Ansari; Darlene Miller; Anat Galor
Journal:  Curr Fungal Infect Rep       Date:  2013-09-01

8.  Antifungal therapy of murine Aspergillus terreus infection.

Authors:  John R Graybill; Steve Hernandez; Rosie Bocanegra; Laura K Najvar
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

9.  Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis.

Authors:  Daoud Al-Badriyeh; Chin Fen Neoh; Kay Stewart; David C M Kong
Journal:  Clin Ophthalmol       Date:  2010-05-06

Review 10.  Newer systemic antifungal agents : pharmacokinetics, safety and efficacy.

Authors:  Helen W Boucher; Andreas H Groll; Christine C Chiou; Thomas J Walsh
Journal:  Drugs       Date:  2004       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.